Skip to content
You are now leaving to visit

Ionis Innovation

Ionis’ antisense technology

With RNA as the target that forms the basis of our novel drug discovery platform, we are tackling an unprecedented range of diseases across a broad set of therapeutic areas. Our antisense therapies are disrupting diseases and, we hope, changing their course—from the rarest of conditions, to those that impact millions of people.

And as we continue to advance our technology, our therapies become more precise and more potent, creating opportunities for us to efficiently bring transformative medicines to patients.

Pioneering a more efficient way to treat disease

Bridging genomic discovery to life-saving therapies, we believe antisense technology is the key to treating the untreatable.

The Ionis antisense advantage

Optimizing antisense through advancements in medicinal chemistry and pioneering new ways to deliver antisense has been a central focus of our research efforts, allowing us to bring options to those who have had none.

A perpetual and efficient innovation machine

Our platform technology has served as a springboard for drug discovery and realized hope for patients with unmet needs. Our broad, diverse pipeline has more than 40 first-in-class and/or best-in-class medicines designed to treat a broad range of diseases.